|
FY2026
12 months to Jul 31, 2026
|
FY2025
12 months to Jul 31, 2025
|
FY2024
12 months to Jul 31, 2024
|
FY2023
12 months to Jul 31, 2023
|
FY2022
12 months to Jul 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net Income Loss | |||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Change in fair value of derivative liability | |||||
| Loss on debt extinguishment | |||||
| Amortization of debt discount and issuance cost | |||||
| Conversion of convertible senior notes attributable to debt discount and issuance costs | |||||
| Operating lease cost, net of accretion | |||||
| Early exit of lease-related assets | |||||
| Gain On Frame Divestiture | |||||
| Non-cash interest expense | |||||
| Inducement expense from partial repurchase of the 2027 Notes | |||||
| Deferred income taxes | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Deferred commissions | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued compensation and benefits | |||||
| Accrued expenses and other liabilities | |||||
| Operating leases, net | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Maturities of investments | |||||
| Purchases of investments | |||||
| Sales of investments | |||||
| Proceeds from Frame divestiture | |||||
| Payments for acquisitions, net of cash acquired | |||||
| Purchases of property and equipment | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Repayment of convertible notes | |||||
| Payments of debt extinguishment costs | |||||
| Proceeds from unwinding of convertible note hedges | |||||
| Payments for unwinding of warrants | |||||
| Proceeds from sales of shares through employee equity incentive plans | |||||
| Proceeds from sales of shares through private placement | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Proceeds from the issuance of convertible notes, net of issuance costs | |||||
| Payment of third-party debt issuance costs | |||||
| Partial repurchase of the 2027 Notes | |||||
| Payment of revolver issuance costs | |||||
| Repurchases of common stock | |||||
| Other financing activities, net | |||||
| Payment of finance lease obligations | |||||
| Deferred payment of purchases of property and equipment | |||||
| Net cash (used in) provided by financing activities | |||||
| Net increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash—beginning of period | |||||
| Cash, cash equivalents and restricted cash—end of period | |||||
| Restricted cash | |||||
| Cash and cash equivalents—end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosures of non-cash investing and financing information: | |||||
| Purchases of property and equipment included in accounts payable and accrued and other liabilities | |||||
| Forfeited paid-in-kind interest recognized in equity upon note conversion | |||||
| Unpaid taxes related to net share settlement of equity awards included in accrued expenses and other liabilities | |||||
Loading...